Incretin-based therapy: a new horizon in diabetes management

Journal of Diabetes & Metabolic Disorders, Journal Year: 2024, Volume and Issue: 23(2), P. 1665 - 1686

Published: Aug. 17, 2024

Language: Английский

---

Highlights of the current issue

Diabetes & Metabolic Syndrome Clinical Research & Reviews, Journal Year: 2024, Volume and Issue: 18(5), P. 103062 - 103062

Published: May 1, 2024

Language: Английский

---

Oral semaglutide improves glycemic control and lowers blood lipids: evidence from a real-world study

Cardiovascular Endocrinology & Metabolism, Journal Year: 2024, Volume and Issue: 13(4)

Published: Sept. 26, 2024

Background The increasing global prevalence of type 2 diabetes necessitates innovative treatment strategies to mitigate not only hyperglycemia but also its associated cardiovascular risks. Oral semaglutide, a glucagon-like peptide-1 receptor agonist, has shown high efficacy in lowering glucose and inducing weight loss randomized trials. However, evidence beneficial effects daily clinical practice is limited. In this study we determined the real-world effectiveness oral semaglutide investigated whether it impacts metabolic parameters beyond control patients with moderate risk. Methods single-center outpatient setting, 53 treated were retrospectively analyzed. Changes anthropometric measurements laboratory over follow-up period 3–9 months assessed. Results significantly improved glycemic facilitated loss, 50% achieving body ≥5% setting. Moreover, reduced alanine aminotransferase hepatic steatosis index significantly. on stable lipid-lowering therapy, observed significant reduction total cholesterol low-density lipoprotein levels following semaglutide. Effects liver inflammation control, whereas control. Conclusion This demonstrates suggesting potential comprehensive risk management individuals diabetes. Research optimize use care may further increase effects.

Language: Английский

---

Reality of Real-World Experience with Oral Semaglutide in Type 2 Diabetes

Clinical Diabetology, Journal Year: 2024, Volume and Issue: 13(6), P. 319 - 322

Published: Dec. 20, 2024

Clinical Diabetology is a bimonthly, open access journal of scientific and educational profile, which was created by combining the assumptions Experimental (Diabetologia Doświadczalna i Kliniczna)

Language: Английский

---